Skip to main content

RIP-CHIP in Drug Development

  • Protocol
  • First Online:
Microarray Methods for Drug Discovery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 632))

Abstract

Microarrays are extensively used to evaluate the effects of compounds on gene expression in the cells. Most of the studies so far have analyzed the transcriptome of the cell. The basic assumption of this approach is that the changes in gene expression occur at the level of transcription of a gene. However, changes often occur at the posttranscriptional level and are not reflected in the analysis of whole transcriptome. We have pioneered the development of “ribonomic profiling” as a high-throughput method to study posttranscriptional regulation of gene expression in the cell. This method is also often referred to as RIP-CHIP. In this chapter, we describe how to use the RIP-CHIP technology to assess the posttranscriptional changes occurring in the cell in response to treatment with a drug.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Braxton S, Bedilion T (1998) Integration of microarray information in the drug development process. Curr Opin Biotechnol 9:643-649

    Article  PubMed  CAS  Google Scholar 

  2. Gunther EC, Stone DJ, Gerwien RW, Bento P, Heyes MP (2003) Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles in vitro. Proc Natl Acad Sci USA 100(16):9608-9613

    Article  PubMed  CAS  Google Scholar 

  3. Lord PG, Nie A, McMillian M (2006) Applications of Genomics in preclinical drug safety evaluation. Basic Clin Pharmacol Toxicol 98(6):537-546

    Article  PubMed  CAS  Google Scholar 

  4. http://www.fda.gov/nctr/science/centers/toxicoinformatics/ArrayTrack/index.htm

  5. Moore MJ (2005) From birth to death: the complex lives of eukaryotic mRNAs. Science 309:1514-1518

    Article  PubMed  CAS  Google Scholar 

  6. Keene JD (2001) Ribonucleoprotein infrastructure regulating the flow of genetic information between the genome and the proteome. Proc Natl Acad Sci USA 98(13):7018-7024

    Article  PubMed  CAS  Google Scholar 

  7. Sanchez-Diaz P, Penalva LO (2006) Post-transcription meets post-genomic: the saga of RNA binding proteins in a new era. RNA Biol 3(3):101-109

    Article  PubMed  CAS  Google Scholar 

  8. Keene JD (2002) Tenenbaum SA: eukaryotic mRNPs may represent posttranscriptional operons. Mol Cell 9(6):1161-1167

    Article  PubMed  CAS  Google Scholar 

  9. Hieronymus H, Silver P (2004) A systems view of mRNP biology. Genes Dev 18:2845-2860

    Article  PubMed  CAS  Google Scholar 

  10. López de Silanes I, Lal A, Gorospe M (2005) HuR: post-transcriptional paths to malignancy. RNA Biol 2(1):11-13

    Article  PubMed  Google Scholar 

  11. Mazan-Mamczarz K, Hagner PR, Corl S, Srikantan S, Wood WH, Becker KG, Gorospe M, Keene JD, Levenson AS, Gartenhaus RB (2008) Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene 27:6151-6163

    Article  PubMed  CAS  Google Scholar 

  12. Mazan-Mamczarz K, Patrick RH, Dai B, Wood WH, Zhang Y, Becker KG, Liu Z, Gartenhaus RB (2008) Identification of transformation-related pathways in a breast epithelial cell model using a ribonomics approach. Cancer Res 68:7730-7735

    Article  PubMed  CAS  Google Scholar 

  13. Kato T, Hayama S, Yamabuki T, Ishikawa N, Miyamoto M, Ito T, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y (2007) Increased expression of insulin-like growth factor-II messenger RNA binding protein-1 is associated with tumor progression in patients with lung cancer. Clin Cancer Res 13:434-442

    Article  PubMed  CAS  Google Scholar 

  14. Tenenbaum SA, Carson CC, Lager PJ, Keene JD (2000) Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc Natl Acad Sci USA 97:14085-14090

    Article  PubMed  CAS  Google Scholar 

  15. Tenenbaum SA, Lager PJ, Carson CC, Keene JD (2002) Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays. Methods 26(2):191-198

    Article  PubMed  CAS  Google Scholar 

  16. Penalva LO, Tenenbaum SA, Keene JD (2004) Gene expression analysis of messenger RNP complexes. Methods Mol Biol 257:125-134

    PubMed  CAS  Google Scholar 

  17. Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco MA (2002) Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods 26(2):182-190

    Article  PubMed  CAS  Google Scholar 

  18. Affymetrix. GeneChip WT sense strand target labeling assay manual, 701880. http://www.affymetrix,com/support/downloads/manuals/wt_sensetarget_label_manual

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Scott A. Tenenbaum .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Humana Press, a part of Springer Science+Business Media, LLC

About this protocol

Cite this protocol

Jain, R. et al. (2010). RIP-CHIP in Drug Development. In: Chittur, S.V. (eds) Microarray Methods for Drug Discovery. Methods in Molecular Biology, vol 632. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-663-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-663-4_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-662-7

  • Online ISBN: 978-1-60761-663-4

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics